Laia Ruiz

Top-line Takeaways: New COVID-19 Vaccines Trials in Sub-Saharan Africa (UBUNTU trial)

Last April 6, the COVID Advocates Advisory Board (CAAB), the Coalition to Accelerate and Support Prevention Research (CASPR) and AVAC held a webinar with Dr. Nigel Garrett, from the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and international Co-chair on the COVPN 3008 Ubuntu mRNA vaccine trial. “It is key to …

Top-line Takeaways: New COVID-19 Vaccines Trials in Sub-Saharan Africa (UBUNTU trial) Read More »

CAAB Vax meets Johnson & Johnson/Janssen to clarify doubts on its covid-19 vaccine

Last November 15, a group of advocates working on vaccine access issues met with representatives of Johnson & Johnson (J&J)/Janssen to discuss issues related to the company’s mono-dose vaccine, popularly known as the Janssen Adeno26 COVID vaccine. The meeting was an opportunity for advocates to pose questions dealing with the safety issues, dosage, the current …

CAAB Vax meets Johnson & Johnson/Janssen to clarify doubts on its covid-19 vaccine Read More »

Alex Mecl

The need to build vaccine confidence

With the spread of covid-19, we see the challenge of vaccine low intake in countries with access to vaccines. But it’s not only about covid-19, vaccine low intake contributes to 1.5 million deaths annually from vaccine preventable diseases.